###BASE_URL###

GENET-news

To stay informed you can subscribe to the GENET-news list.

 

2009-05-19 |

U.S. Federal Circuit limits patentability of genetic sequences

The Federal Circuit’s decision in Kubin generally means that to the extent a protein has been previously identified, its nucleotide sequence is no longer patentable. The broader application of Kubin will include attempts to reject or invalidate claims directed to biotech inventions which claim an outcome of experimentation from among a range of expected results, even though not expressly predictable. There will undoubtedly be an increase in invalidity challenges to existing gene patents by those seeking to market generic and follow-on biologics prior to patent expiration, in view of the likelihood that pending regulatory legislation also passes. Clearly, the patentability standard for gene sequences and the commercial exclusivity available for such biotech inventions have been dramatically altered by the Federal Circuit’s In re Kubin decision.

Overview

News

2009-05-19 |

U.S. Federal Circuit limits patentability of genetic sequences

The Federal Circuit’s decision in Kubin generally means that to the extent a protein has been previously identified, its nucleotide sequence is no longer patentable. The broader application of Kubin will include attempts to reject or invalidate claims directed to biotech inventions which claim an outcome of experimentation from among a range of expected results, even though not expressly predictable. There will undoubtedly be an increase in invalidity challenges to existing gene patents by those seeking to market generic and follow-on biologics prior to patent expiration, in view of the likelihood that pending regulatory legislation also passes. Clearly, the patentability standard for gene sequences and the commercial exclusivity available for such biotech inventions have been dramatically altered by the Federal Circuit’s In re Kubin decision.

Home: GENET

GENET-news & GENET-forum

GENET-news is providing a daily news service on a range of topics regarding genetic engineering. We are screening the worldwide English news, press releases and other publications to provide you with a strategic selection of information. GENET-news enables you to stay informed about all aspects of the global controversy around GE technologies and GE organisms. You can subscribe by  email.

The GENET-forum list provides you with additional background information and more voluminous reports. It is only open for GENET members. Please contact the  coordinator for membership and subscription.